Prescribing Controlled Substances for MD/DO Prescribers

On March 19, 2018, Gov. Rick Scott signed bill HB 21 into law which includes a variety of measures to combat the opioid crisis. The bill states that each person registered with the United States Drug Enforcement Administration and authorized to prescribe controlled substances shall complete a board-approved two-hour continuing education (CE) course on prescribing controlled substances. The Florida Medical Association (FMA) is authorized by HB 21 to provide this two-hour mandatory requirement for MDs and DOs. Although only DEA-registered prescribers of controlled substances are actually required to complete this training every two years, all physicians are welcome to complete this course. All CME credit earned will be reported to CE Broker. HB 21 required prescribers to complete this course for the first time no later than January 31, 2019 and then for each subsequent renewal thereafter.

Learning Objectives

After completing this activity, learners will be able to:

  • Recognize the relevant prescribing laws and rules that govern prescribers of controlled substances in Florida
  • Compare and contrast scheduled drugs related to treatment of pain, both acute and chronic nonmalignant pain
  • List alternative pharmacologic options, non-pharmacologic methods and procedures, and complementary and alternative treatment options for managing pain
  • Apply concepts of SBIRT (screening, brief intervention and referral to treatment) and motivational interviewing within patient encounters  
  • Utilize appropriate screening tools such as ORT®, SOAPP-R®, COMM™, UDS, E-FORCSE® and others to identify patients at risk for misuse or who are addicted to controlled substances
  • Implement appropriate monitoring and referrals for patients who are prescribed controlled substances
  • List appropriate screening and documentation requirements for prescribing controlled substances in patients experiencing pain
  • State national recommendations on the safe levels of opioids by morphine milligram dose equivalents and durations of treatment for acute and chronic nonmalignant pain

Additional Information

Partner: 
Florida Medical Association
State Approved: 
Florida
Course summary
Available credit: 
  • 2.00 AMA PRA Category 1 Credit™
Course opens: 
10/05/2018
Course expires: 
12/31/2024
Nonmember cost:
$75.00
Member cost:
$25.00
Rating: 
0

Available Credit

  • 2.00 AMA PRA Category 1 Credit™

Price

Nonmember cost:
$75.00
Member cost:
$25.00
Please login or register to take this course.

This course is offered through Florida Medical Association. 

To take this course you will be redirected to Florida Medical Association's website. You must login or create an account with Florida Medical Association in order to complete this activity. 

Mocingbird works to provide curated, high quality content to our users. Have a suggestion? Want to partner with us? Get in touch!